tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ICLR Stock Latest News

BofA shakes up ratings in Biopharma Services with seven changes
The FlyBofA shakes up ratings in Biopharma Services with seven changes
14d ago
CRL
MTD
Icon downgraded to Neutral from Buy at BofA
PremiumThe Fly
Icon downgraded to Neutral from Buy at BofA
14d ago
ICLR
Icon price target raised to $200 from $185 at Barclays
PremiumThe Fly
Icon price target raised to $200 from $185 at Barclays
14d ago
ICLR
Jefferies says market thinking ‘backwards’ on FDA one trial proposal
PremiumThe Fly
Jefferies says market thinking ‘backwards’ on FDA one trial proposal
23d ago
IQV
FTRE
FDA shift in drug study requirements sends trial runners lower
PremiumThe Fly
FDA shift in drug study requirements sends trial runners lower
25d ago
AZN
BMY
FDA to reduce number of trials required for drug approvals, STAT reports
PremiumThe FlyFDA to reduce number of trials required for drug approvals, STAT reports
25d ago
AZN
BMY
Icon’s Hold Rating: Navigating Leadership Transition and Customer Challenges Amid Market Recovery
Premium
Ratings
Icon’s Hold Rating: Navigating Leadership Transition and Customer Challenges Amid Market Recovery
25d ago
ICLR
Icon initiated with a Market Perform at BMO Capital
Premium
The Fly
Icon initiated with a Market Perform at BMO Capital
2M ago
ICLR
ICON plc to Present at Jefferies London Healthcare Conference
PremiumCompany Announcements
ICON plc to Present at Jefferies London Healthcare Conference
2M ago
6K
ICLR
New Phase 2b Trial by Icon Plc and Bavarian Nordic: A Closer Look at MVA-BN Vaccine Developments
PremiumCompany Announcements
New Phase 2b Trial by Icon Plc and Bavarian Nordic: A Closer Look at MVA-BN Vaccine Developments
2M ago
ICLR
ICON plc’s Earnings Call: Balancing Growth and Challenges
PremiumCompany Announcements
ICON plc’s Earnings Call: Balancing Growth and Challenges
2M ago
ICLR
Icon price target lowered to $172 from $183 at TD Cowen
PremiumThe Fly
Icon price target lowered to $172 from $183 at TD Cowen
2M ago
ICLR
Icon price target lowered to $220 from $240 at UBS
PremiumThe FlyIcon price target lowered to $220 from $240 at UBS
2M ago
ICLR
Icon price target raised to $220 from $218 at Baird
Premium
The Fly
Icon price target raised to $220 from $218 at Baird
2M ago
ICLR
Icon price target lowered to $185 from $190 at Barclays
Premium
The Fly
Icon price target lowered to $185 from $190 at Barclays
2M ago
ICLR
ICON plc Reports Steady Q3 2025 Growth Amid Challenges
PremiumCompany Announcements
ICON plc Reports Steady Q3 2025 Growth Amid Challenges
2M ago
ICLR
Hold Rating for Icon Amid Margin Pressure and Revenue Challenges
PremiumRatings
Hold Rating for Icon Amid Margin Pressure and Revenue Challenges
2M ago
ICLR
ICON Announces CEO Transition and Updates on Share Repurchase and Vaccine Study
PremiumCompany Announcements
ICON Announces CEO Transition and Updates on Share Repurchase and Vaccine Study
2M ago
6K
ICLR
Optimistic Buy Rating for Icon Amid Market Concerns and Margin Questions
PremiumRatings
Optimistic Buy Rating for Icon Amid Market Concerns and Margin Questions
2M ago
ICLR
Icon price target lowered to $220 from $235 at Leerink
PremiumThe FlyIcon price target lowered to $220 from $235 at Leerink
2M ago
ICLR
Icon’s Resilience and Growth Potential Justifies Buy Rating Despite Mixed Q3 Performance
Premium
Ratings
Icon’s Resilience and Growth Potential Justifies Buy Rating Despite Mixed Q3 Performance
2M ago
ICLR
ICON plc Reports Third Quarter 2025 Financial Results
Premium
Company Announcements
ICON plc Reports Third Quarter 2025 Financial Results
2M ago
6K
ICLR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >